Drug

Retagliptin clinical trials

Also written SP2086.

Includes 1 study of Retagliptin phosphate.

studies test it: 17
open now: 1
in phase 3: 2
first study started: 2011

Keep track of what changes. Save the retagliptin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

SP2086: 11

Combined with it in one product

SP2086(50 mg q.d.)/Metformin: 1
SP2086 (100 mg q.d.)/Metformin: 1
SHR3824, SP2086: 1
Henagliflozin, Retagliptin: 1

Studies by the year they started

17 studies that test it; most in 2016 (5)

Studies that test retagliptin, by start year
Year	Studies
2011	1
2012	2
2013	3
2014	2
2015	3
2016	5
2023	1

By phase

A phase 1/2 study counts in both.

Phase 1: 13
Phase 2: 2
Phase 3: 2

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2: 6
Renal Insufficiency: 1

Who runs them

Industry 17 · Other 0

Jiangsu HengRui Medicine Co., Ltd. (17)

Often tested with

Tested in the same studies.

Simvastatin (2) · Valsartan (2) · Metformin (2) · Glyburide (1) · Henagliflozin (1)

Studies

Open first, then newest update. How each study uses retagliptin is read from its arms, and is right about nine times in ten.

Testing it · 17

Codes

What other systems call retagliptin · ClinicalTrials.gg INT014575

UNII (FDA) 328C4R3P9LRETAGLIPTINConfirmed FDA, Wikidata
Wikidata Q76545709retagliptinConfirmed FDA, Wikidata
NCI Thesaurus C223504RetagliptinOne source FDA
DrugBank DB14898One source Wikidata

System	Code	Name there	Checked by
UNII (FDA)	328C4R3P9L	RETAGLIPTIN	Confirmed FDA, Wikidata
Wikidata	Q76545709	retagliptin	Confirmed FDA, Wikidata
NCI Thesaurus	C223504	Retagliptin	One source FDA
DrugBank	DB14898	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.